New Drug for Alzheimer Disease Shows Promise in Phase 3 Trial
WEDNESDAY, Sept. 28, 2022 (HealthDay) — Japanese drugmaker Eisai on Wednesday said its experimental drug lecanemab helped slow thinking declines among people in the early stages of Alzheimer disease.The findings from a phase 3 clinical trial have yet…
Learn MoreTwo Cases Show COVID Virus Mutating Around Standard Treatment Remdesivir
WEDNESDAY, Sept. 28, 2022 (HealthDay News) — Patients with weakened immune systems could be inadvertently helping COVID-19 develop resistance to the antiviral drug remdesivir, a new study reports.After lengthy COVID infections, two kidney transplant …
Learn MoreSemaglutide Reduces 10-Year Risk for T2D in Obese Persons
TUESDAY, Sept. 27, 2022 (HealthDay News) — Semaglutide reduces the 10-year risk for type 2 diabetes (T2D) in obese or overweight individuals, and sustained treatment is needed to maintain this risk reduction, according to a study presented at the ann…
Learn MoreTriplet Therapy Ups Progression-Free Survival in Advanced Kidney Cancer
MONDAY, Sept. 26, 2022 (HealthDay News) — Triplet therapy of cabozantinib + nivolumab + ipilimumab significantly improves progression-free survival (PFS) compared with placebo + nivolumab + ipilimumab for patients with previously untreated advanced r…
Learn MoreContinuation of Anti-TNF for IBD After 24 Weeks of Pregnancy Beneficial
MONDAY, Sept. 26, 2022 (HealthDay News) — For women with inflammatory bowel disease (IBD), continuation of anti-tumor necrosis factor (TNF) after 24 weeks of pregnancy seems beneficial in terms of IBD activity and prematurity, according to a study pu…
Learn More¿Ya toma un anticoagulante? Añadir aspirina podría ser nocivo
MIÉRCOLES, 21 de septiembre de 2022 (HealthDay News) — Durante muchos años, los médicos han aconsejado tomar aspirina en dosis baja para ayudar a prevenir un primer ataque cardiaco o accidente cerebrovascular (ACV). Pero están cambiando de opinión co…
Learn MoreAlready Taking a Blood Thinner? Adding Aspirin May Do Harm
WEDNESDAY, Sept. 21, 2022 (HealthDay News) — For many years, doctors have advised taking low-dose aspirin to help prevent first-time heart attacks and stroke. But increasingly, they’re doing an about-face.The latest warnings come from University of M…
Learn More‘Life Changing’: New Drug Eases Severe Eczema in Young Kids
TUESDAY, Sept 20, 2022 (HealthDay News) — Sonia Dhaliwal knows exactly how bad childhood eczema can get.That’s because her young daughter, Ariah Khan, has struggled with a severe case of the skin condition ever since she was a baby.Ariah’s symptoms w…
Learn MoreBebtelovimab Appears Reliable for COVID-19 During Omicron Epoch
MONDAY, Sept. 19, 2022 (HealthDay News) — For high-risk patients with mild-to-moderate COVID-19 during the omicron epoch, bebtelovimab seems to be a reliable treatment option, according to a study published online Sept. 17 in the Journal of Infecti…
Learn MoreDaily Timing of Antihypertensives Does Not Impact Effectiveness
FRIDAY, Sept. 16, 2022 (HealthDay News) — Antihypertensive medication effectiveness for protecting against heart attack, stroke, and vascular death is not affected by whether the medication is taken in the morning or evening, according to a late-brea…
Learn More
English
Spanish